{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/03/3337366/28908/en/Tonix-Pharmaceuticals-Announces-Positive-Minutes-from-Type-C-FDA-Meeting-to-Discuss-Adaptive-Phase-2-Field-Study-of-TNX-4800-a-Human-anti-OspA-Monoclonal-Antibody-to-Prevent-Lyme-D.html", "message": "News view counter 862896 successfully enlarged"}